세계의 크로마토그래피 시스템 시장(2023-2030년)

Overview

The global chromatography systems market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Systems for purification called chromatography enable the separation of particular substances from complicated mixtures. Based on interactions between the sample and stationary phase, separation takes place.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced systems or consumables and boost the global chromatography systems market. The respective innovative chromatography are in various types such as liquid, gas or column chromatography.

Market Dynamics: Drivers & Restraints

Growing collaborations and acquisitions

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for chromatography systems owing to the rising research. Various collaborations, acquisitions and product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.

On June 5, 2023, in order to build on their prior collaboration on upstream bioprocessing analytics, Waters Corporation with Sartorius established a new partnership to create integrated analytical products for downstream biomanufacturing. Bioprocess engineers will have access to more thorough analytical data for downstream batch and continuous manufacturing thanks to software and hardware integrations involving the PATROL UltraPerformance Liquid Chromatography (UPLC) Process Evaluation System of Waters as well as the Sartorius Resolute BioSMB multi-column chromatography platform. This will increase yields while decreasing waste and lowering biomanufacturing costs.

Additionally, on February 8, 2022, following the U.S. Federal Trade Commission's permission, Sartorius Stedim Biotech, a prominent partner in the biopharma sector, completed its purchase of the Novasep chromatography division. The portfolio that was acquired includes cutting-edge equipment for the continuous production of biologics as well as chromatography systems that are best suited for smaller biomolecules including oligonucleotides, peptides, and insulin.

Furthermore, the rising utilization of novel technology and different types of systems for the several research purposes. Rising chronic disorders and increasing research for innovative diagnostic product development will be a major factor driving the growth of the chromatography systems market.

High cost associated with the chromatography systems

There are several kinds of systems, and they all depend on the same elements to produce reliable outcomes. However, many laboratories may find it difficult to afford this equipment because of its high cost. While outright acquisition of a brand-new or used liquid chromatography system may not be viable given the available funds, leasing the machinery at a reasonable cost is a great choice.

Equipment for liquid chromatography can be purchased for anywhere between $10,000 and $30,000. Systems for more sophisticated liquid chromatography that include autosamplers, high-pressure pumps, and detection modules can cost anywhere between $40,000 to more than $100,000. These systems have substantial equipment, pricey sensors, and intricate internal mechanics. These systems have a base price, but they can also be expensive to operate and maintain.

Segment Analysis

The global chromatography systems market is segmented based on product type, modality, application, end user and region.

Systems segment accounted for approximately 54% of market share

Chromatography systems include with all the tools necessary for separating samples, a power source, and programming software. Chromatography systems are used in all biotechnology fields, from little research labs to enormous manufacturing facilities. For separation, various technologies are available.

The chemical and physical characteristics of the substance, such as chemical reactivity, size, mass, and form, as well as laboratory needs, including flow process, validation requirements, and sample tracking, must all be taken into account when choosing a chromatography system. With the use of mass spectrometry equipment, liquid and gas chromatography can be used to identify unknown compounds, as well as to ascertain the isotopic makeup of the elements in a molecule and to ascertain the compounds structure by watching its fragmentation.

June 12, 2023, Agilent Technologies Inc. will present their greatly enhanced InfinityLab GPC/SEC System at the HPLC 2023 conference. The recent acquisition of Polymer Standard Service Ltd. (PSS) by Agilent has resulted in the addition of value-added components to the portfolio of InfinityLab GPC/SEC solutions for advanced material characterization, including a Multi-Angle Light Scattering Detector, an exclusive GPC/SEC Column Thermostat, the GPC/SEC-Ready Kit, along with the potent WinGPC Software.

Geographical Penetration

North America accounted for around 34% of market share in 2022

Due to the rising need for chromatography systems in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chromatography systems.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or biotechnology business establishment across the region are also contributing to the growth of chromatography systems market share of this region. The market in this area is growing as people become more aware of various novel innovative systems. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chromatography systems market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chromatography systems in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chromatography systems demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chromatography systems market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chromatography systems. Now several research studies have been initiated and companies have again started trial for their products efficiency. Overall, the impact of the pandemic on the global chromatography systems market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like multiple-use systems.

Key Developments

• On June 5, 2023, The Agilent Revident LC/Q-TOF and the Agilent 6495D LC/TQ are two new liquid chromatography mass spectrometry (LCMS) systems from Agilent Technologies Inc. Agilent also introduced the new Agilent ChemVista library manager software and the new Agilent MassHunter Explorer Profiling software, enabling the high-end capabilities of the Revident LC/Q-TOF.
• On June 29, 2022, Low-Pressure Prepacked EconoFit Chromatography Column Packs were introduced by Bio-Rad Laboratories, Inc., a pioneer in life science investigation and clinical diagnostic products, to help resin screening tests in the creation of protein purification workflows.

Competitive Landscape

The major global players in the market include: Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Cytiva, Agilent Technologies Inc., Bruker, PerkinElmer Inc., Merck KGaA, Sartorius AG, Shimadzu Corporation and Waters Corporation.

Why Purchase the Report?

• To visualize the global chromatography systems market segmentation based on product type, modality, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of chromatography systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gene prediction tool market report would provide approximately 69 tables, 70 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Modality
• 3.3. Snippet by Application
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing collaborations and acquisitions
    • 4.1.1.2. Rising technological advancements and developments
  • 4.1.2. Restraints
    • 4.1.2.1. Limitations associated with the chromatography systems
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. SWOT Analysis
• 5.6. Patent Analysis
• 5.7. Russia-Ukraine War Impact Analysis
• 5.8. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Systems*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. Liquid Chromatography Systems
    • 7.2.3.1. Ultra High Performance Liquid Chromatography Systems
    • 7.2.3.2. High Performance Liquid Chromatography Systems
    • 7.2.3.3. Medium Pressure Liquid Chromatography Systems
    • 7.2.3.4. Others
  • 7.2.4. Gas Chromatography Systems
    • 7.2.4.1. Gas-Liquid Chromatography (GLC)
    • 7.2.4.2. Gas-Solid Chromatography (GSC)
  • 7.2.5. Thin Layer Chromatography
    • 7.2.5.1. High Pressure Thin Layer Chromatography (HPTLC)
    • 7.2.5.2. Thin Layer Chromatography Mass Spectrometry
  • 7.2.6. Ion Chromatography
  • 7.2.7. Others
• 7.3. Consumables
• 7.4. Software

8. By Modality

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 8.1.2. Market Attractiveness Index, By Modality
• 8.2. Single-use Systems*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Multiple-use Systems

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Drug and Clinical Testing *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Food and Beverage
• 9.4. Environmental and Chemical Industry
• 9.5. Forensics
• 9.6. Petroleum
• 9.7. Others

10. By End User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.1.2. Market Attractiveness Index, By End User
• 10.2. Pharmaceutical Companies*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Biotechnology and Life Science Companies
• 10.4. Diagnostic Centers
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Thermo Fisher Scientific Inc.*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Bio-Rad Laboratories, Inc.
• 13.3. Cytiva
• 13.4. Agilent Technologies Inc.
• 13.5. Bruker
• 13.6. PerkinElmer Inc.
• 13.7. Merck KGaA
• 13.8. Sartorius AG
• 13.9. Shimadzu Corporation
• 13.10. Waters Corporation

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us